PMC4310101_01
(a) The coronal 18F-fluorodeoxyglucose (18FDG)-positronemission tomography/computed tomography scans show, (blue arrow: Primary cancer, green arrow: Bladder FDG accumulation), SUVmax: 12.4, (b) maximum intensity projection images, (blue arrow: Primary cancer, green arrow: Bladder)
UA-7-115-g001.jpg
PMC4310101_01_UA-7-115-g001.jpg
F1
Late pelvic images of FDG-PET/CT revealed an activity of the primary tumor measuring 32 mm in diameter in the right lobe of the prostate with a standard uptake value (SUVmax) of 12.4 [Figure 1].
(a) The coronal 18F-fluorodeoxyglucose-positron-emission tomography/computed tomography scans show, red arrow: Lung metastasis, SUVmax: 10.9. Blue arrows: Liver metastases SUVmax: 10.3 and 9.6, (b) maximum intensity projection images, (red arrow: Lung metastasis, blue arrows: Liver metastases)
UA-7-115-g002.jpg
PMC4310101_01_UA-7-115-g002.jpg
F2
Metastatic lesions were observed, measuring 18 mm in the anterobasal lobe of the right lung (SUVmax: 8.1) and 26 mm in the right (SUVmax: 10.3) and 17 mm in the left lobe (SUVmax: 9.6) of the liver [Figure 2].
(a) H and E, demonstrating, tumor composed of spindle cells (H and E, x40), (b) H and E, demonstrating, tumor composed of spindle cells (H and E, x100), (c) immunohistochemistry showing, desmin (x200), (d) immunohistochemistry showing, actin (x40)
UA-7-115-g003.jpg
PMC4310101_01_UA-7-115-g003.jpg
F3
Immunohistochemical examination revealed positive staining for smooth muscle actin, vimentin, and desmin and negative staining for CD34, S100 and progesterone receptors [Figure 3].